The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
Open accessAbstract
N6-methyladenosin (m6A) is one of the most pervasive modification of mRNA in eukaryotes and the m6A methyltransferases and demethylases play critical roles in many types of cancer. However the role of m6A-binding proteins in cancer remains elusive. Here we report that the down-regulation of YTHDF2 was specifically induced by hypoxia in hepatocellular carcinoma (HCC) cells, and that overexpression of YTHDF2 suppressed cell proliferation, tumor growth and activation of MEK and ERK in HCC cells. Mechanistically, YTHDF2 directly bound the m6A modification site of EGFR 3’-UTR to promote the degradation of EGFR mRNA in HCC cells. This is the first report showing that YTHDF2 may act as a tumor suppressor to repress cell proliferation and growth via destabilizing the EGFR mRNA in HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
N6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Wang, X., Zhao, B. S., Roundtree, I. A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., & He, C. (2015) · Cell · doi:10.1016/j.cell.2015.05.014 · Cited by 3,483
Self-citationTargeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Roberts, P. J., & Der, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210422 · Cited by 2,788
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing
Xiao, W., Adhikari, S., Dahal, U., Chen, Y.-S., Hao, Y.-J., Sun, B.-F., Sun, H.-Y., Li, A., Ping, X.-L., Lai, W.-Y., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.012 · Cited by 2,054
Self-citationYTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA
Shi, H., Wang, X., Lu, Z., Zhao, B. S., Ma, H., Hsu, P. J., Liu, C., & He, C. (2017) · Cell Research · doi:10.1038/cr.2017.15 · Cited by 1,815
Self-citationThe m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells
Lin, S., Choe, J., Du, P., Triboulet, R., & Gregory, R. I. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.021 · Cited by 1,531
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase
Li, Z., Weng, H., Su, R., Weng, X., Zuo, Z., Li, C., Huang, H., Nachtergaele, S., Dong, L., Hu, C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.017 · Cited by 1,508
Du, H., Zhao, Y., He, J., Zhang, Y., Xi, H., Liu, M., Ma, J., & Wu, L. (2016) · Nature Communications · doi:10.1038/ncomms12626 · Cited by 1,463
Zhang, S., Zhao, B. S., Zhou, A., Lin, K., Zheng, S., Lu, Z., Chen, Y., Sulman, E. P., Xie, K., Bögler, O., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.013 · Cited by 1,459
YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs
Roundtree, I. A., Luo, G.-Z., Zhang, Z., Wang, X., Zhou, T., Cui, Y., Sha, J., Huang, X., Guerrero, L., Xie, P., et al. (2017) · eLife · doi:10.7554/elife.31311 · Cited by 1,256
Rethinking m6A Readers, Writers, and Erasers
Meyer, K. D., & Jaffrey, S. R. (2017) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060758 · Cited by 1,150
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Su, R., Dong, L., Li, C., Nachtergaele, S., Wunderlich, M., Qing, Y., Deng, X., Wang, Y., Weng, X., Hu, C., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.031 · Cited by 1,137
Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis
Hsu, P. J., Zhu, Y., Ma, H., Guo, Y., Shi, X., Liu, Y., Qi, M., Lu, Z., Shi, H., Wang, J., et al. (2017) · Cell Research · doi:10.1038/cr.2017.99 · Cited by 1,005
Self-citationZhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.016 · Cited by 968
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962
RNA N6-methyladenosine modification in cancers: current status and perspectives
Deng, X., Su, R., Weng, H., Huang, H., Li, Z., & Chen, J. (2018) · Cell Research · doi:10.1038/s41422-018-0034-6 · Cited by 845
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Whittaker, S., Marais, R., & Zhu, A. X. (2010) · Oncogene · doi:10.1038/onc.2010.236 · Cited by 825
Reading m6A in the Transcriptome: m6A-Binding Proteins
Patil, D. P., Pickering, B. F., & Jaffrey, S. R. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.10.001 · Cited by 628
m6A modulates haematopoietic stem and progenitor cell specification
Zhang, C., Chen, Y., Sun, B., Wang, L., Yang, Y., Ma, D., Lv, J., Heng, J., Ding, Y., Xue, Y., et al. (2017) · Nature · doi:10.1038/nature23883 · Cited by 582
m6A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition
Zhao, B. S., Wang, X., Beadell, A. V., Lu, Z., Shi, H., Kuuspalu, A., Ho, R. K., & He, C. (2017) · Nature · doi:10.1038/nature21355 · Cited by 564
Zhu, T., Roundtree, I. A., Wang, P., Wang, X., Wang, L., Sun, C., Tian, Y., Li, J., He, C., & Xu, Y. (2014) · Cell Research · doi:10.1038/cr.2014.152 · Cited by 373
Li, F., Zhao, D., Wu, J., & Shi, Y. (2014) · Cell Research · doi:10.1038/cr.2014.153 · Cited by 268
Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion
Li, Z., Qian, P., Shao, W., Shi, H., He, X. C., Gogol, M., Yu, Z., Wang, Y., Qi, M., Zhu, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0072-0 · Cited by 257
Chapter 17 Messenger RNA Half‐Life Measurements in Mammalian Cells
Chen, C. A., Ezzeddine, N., & Shyu, A. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(08)02617-7 · Cited by 256
Tanabe, A., Tanikawa, K., Tsunetomi, M., Takai, K., Ikeda, H., Konno, J., Torigoe, T., Maeda, H., Kutomi, G., Okita, K., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.022 · Cited by 246
Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer
Nishizawa, Y., Konno, M., Asai, A., Koseki, J., Kawamoto, K., Miyoshi, N., Takahashi, H., Nishida, N., Haraguchi, N., Sakai, D., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23554 · Cited by 226
Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma
Zhao, X., Chen, Y., Mao, Q., Jiang, X., Jiang, W., Chen, J., Xu, W., Zhong, L., & Sun, X. (2018) · Cancer Biomarkers · doi:10.3233/cbm-170791 · Cited by 222
Self-citationEGFR Signaling in Liver Diseases
Komposch, K., & Sibilia, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010030 · Cited by 218
Chen, J., Sun, Y., Xu, X., Wang, D., He, J., Zhou, H., Lu, Y., Zeng, J., Du, F., Gong, A., et al. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1380125 · Cited by 209
m6AVar: a database of functional variants involved in m6A modification
Zheng, Y., Nie, P., Peng, D., He, Z., Liu, M., Xie, Y., Miao, Y., Zuo, Z., & Ren, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx895 · Cited by 190
Tan, B., Liu, H., Zhang, S., da Silva, S. R., Zhang, L., Meng, J., Cui, X., Yuan, H., Sorel, O., Zhang, S.-W., et al. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0056-8 · Cited by 164
N 6 -methyladenosine is required for the hypoxic stabilization of specific mRNAs
Fry, N. J., Law, B. A., Ilkayeva, O., Holley, C. L., & Mansfield, K. D. (2017) · RNA · doi:10.1261/rna.061044.117 · Cited by 126
MAF1 suppresses AKT‐mTOR signaling and liver cancer through activation of PTEN transcription
Li, Y., Tsang, C. K., Wang, S., Li, X., Yang, Y., Fu, L., Huang, W., Li, M., Wang, H., & Zheng, X. F. S. (2016) · Hepatology · doi:10.1002/hep.28507 · Cited by 75
Self-citationHypoxia and Hypoglycemia synergistically regulate mRNA stability
Carraway, K., Johnson, E. M., Kauffmann, T. C., Fry, N. J., & Mansfield, K. D. (2017) · RNA Biology · doi:10.1080/15476286.2017.1311456 · Cited by 19
Cited by
Functions of N6-methyladenosine and its role in cancer
He, L., Li, H., Wu, A., Peng, Y., Shu, G., & Yin, G. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1109-9 · Cited by 1,397
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huang, H., Weng, H., & Chen, J. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.02.004 · Cited by 1,226
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
Niu, Y., Lin, Z., Wan, A., Chen, H., Liang, H., Sun, L., Wang, Y., Li, X., Xiong, X.-F., Wei, B., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1004-4 · Cited by 593
Self-citationThe role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Nombela, P., Miguel-López, B., & Blanco, S. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01263-w · Cited by 492
Zhang, C., Huang, S., Zhuang, H., Ruan, S., Zhou, Z., Huang, K., Ji, F., Ma, Z., Hou, B., & He, X. (2020) · Oncogene · doi:10.1038/s41388-020-1303-7 · Cited by 393
Metadata
- Authors
- Zhong, L., Liao, D., Zhang, M., Zeng, C., Li, X., Zhang, R., Ma, H., & Kang, T.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 442
- Pages
- 252-261
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2899914600
- Cited by
- 372
- References
- 37
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.